JP2014094963A5 - - Google Patents

Download PDF

Info

Publication number
JP2014094963A5
JP2014094963A5 JP2014009382A JP2014009382A JP2014094963A5 JP 2014094963 A5 JP2014094963 A5 JP 2014094963A5 JP 2014009382 A JP2014009382 A JP 2014009382A JP 2014009382 A JP2014009382 A JP 2014009382A JP 2014094963 A5 JP2014094963 A5 JP 2014094963A5
Authority
JP
Japan
Prior art keywords
pdt
use according
light
hexyl ester
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014009382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014094963A (ja
JP5827702B2 (ja
Filing date
Publication date
Priority claimed from GBGB0700580.4A external-priority patent/GB0700580D0/en
Application filed filed Critical
Publication of JP2014094963A publication Critical patent/JP2014094963A/ja
Publication of JP2014094963A5 publication Critical patent/JP2014094963A5/ja
Application granted granted Critical
Publication of JP5827702B2 publication Critical patent/JP5827702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014009382A 2007-01-11 2014-01-22 アミノレブリン酸およびその誘導体の使用 Active JP5827702B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0700580.4 2007-01-11
GBGB0700580.4A GB0700580D0 (en) 2007-01-11 2007-01-11 Use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009545231A Division JP5814508B2 (ja) 2007-01-11 2008-01-11 アミノレブリン酸およびその誘導体の使用

Publications (3)

Publication Number Publication Date
JP2014094963A JP2014094963A (ja) 2014-05-22
JP2014094963A5 true JP2014094963A5 (enExample) 2014-10-02
JP5827702B2 JP5827702B2 (ja) 2015-12-02

Family

ID=37809842

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009545231A Expired - Fee Related JP5814508B2 (ja) 2007-01-11 2008-01-11 アミノレブリン酸およびその誘導体の使用
JP2014009382A Active JP5827702B2 (ja) 2007-01-11 2014-01-22 アミノレブリン酸およびその誘導体の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009545231A Expired - Fee Related JP5814508B2 (ja) 2007-01-11 2008-01-11 アミノレブリン酸およびその誘導体の使用

Country Status (13)

Country Link
US (4) US8759396B2 (enExample)
EP (3) EP2120921B1 (enExample)
JP (2) JP5814508B2 (enExample)
KR (2) KR20090118925A (enExample)
CN (3) CN104069493A (enExample)
CA (2) CA2675334C (enExample)
DK (1) DK2120921T3 (enExample)
ES (2) ES2900528T3 (enExample)
GB (1) GB0700580D0 (enExample)
PL (1) PL2120921T3 (enExample)
PT (1) PT2120921E (enExample)
SI (1) SI2120921T1 (enExample)
WO (1) WO2008084241A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110224598A1 (en) * 2010-03-12 2011-09-15 Daniel Barolet Radiant near infrared light emitting diode exposure as skin preparation
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
KR101797780B1 (ko) * 2009-06-11 2017-11-14 포토큐어 에이에스에이 반고체 조성물 및 약제학적 제품
WO2011107478A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2657346B1 (en) 2010-12-24 2017-08-23 ARKRAY, Inc. Method for detecting cancer cell
CN102617378B (zh) * 2011-01-26 2016-04-27 上海泺安医药技术有限公司 一种2-(3’-氨基-2’-氧-丙基)丙二酸酯盐及制备
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
CN102179010B (zh) * 2011-05-27 2013-01-09 吉林大学 脑胶质瘤光动力直接照射治疗装置
RU2615870C2 (ru) * 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
JP5883889B2 (ja) * 2012-01-26 2016-03-15 Sbiファーマ株式会社 光線力学的診断剤、及び、フォトブリーチング防止剤
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
KR20150004092A (ko) * 2013-07-02 2015-01-12 제너럴바이오(주) 칼란코에 추출물이 포함된 항산화 액상 조성물
EP3082787B1 (en) 2013-12-20 2020-11-25 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
PL229756B1 (pl) 2014-11-12 2018-08-31 Tarchominskie Zaklady Farmaceutyczne Polfa Spólka Akcyjna Krem do stosowania w diagnostyce i terapii z zastosowaniem metody fotodynamicznej
WO2016080096A1 (ja) * 2014-11-19 2016-05-26 シャープ株式会社 光線力学治療装置
EP3362145B1 (en) 2015-10-15 2021-01-06 DUSA Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
CA3008552C (en) 2015-12-17 2024-01-02 Photocure Asa Method of photodynamic therapy (pdt) for bladder cancer
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
EP3655035A4 (en) * 2017-07-17 2021-04-14 Andrea Willey PHOTODYNAMIC THERAPY PROCEDURE FOR SKIN DISEASES
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
WO2020038583A1 (en) 2018-08-23 2020-02-27 Biofrontera Bioscience Gmbh Photodynamic therapy comprising two light exposures at different wavelengths
JPWO2020218577A1 (enExample) 2019-04-26 2020-10-29
JP2022540769A (ja) * 2019-06-25 2022-09-20 デューサ ファーマシューティカルズ インコーポレイテッド 光線性角化症の光線力学的治療の間の痛みを低減する方法
CN115916178A (zh) * 2020-07-15 2023-04-04 日本纽翱医药股份有限公司 非洲猪瘟(African Swine Fever:ASF)的治疗剂和/或预防剂
CN113620828B (zh) * 2021-08-17 2025-04-01 湖南复瑞生物医药技术有限责任公司 一种5-氨基酮戊酸酯化物、用途和农药组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5422093A (en) 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
NZ303251A (en) 1995-03-10 2000-10-27 Photocure Asa Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
AUPQ044499A0 (en) 1999-05-19 1999-06-10 Commonwealth Scientific And Industrial Research Organisation Control of wool growth
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
JP2004506005A (ja) * 2000-08-16 2004-02-26 ザ ジェネラル ホスピタル コーポレイション ディー ビー エイ マサチューセッツ ジェネラル ホスピタル 尋常性挫瘡用の局所アミノレブリン酸−光力学的治療
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
AU2003230808A1 (en) 2002-04-05 2003-10-27 Candela Corporation High fluence rate activation of photosensitizers for dermatological applications
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
WO2004034889A2 (en) 2002-10-18 2004-04-29 The Regents Of The University Of California Photodynamic therapy for ocular neovascularization
US20050209331A1 (en) 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209330A1 (en) 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) * 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product

Similar Documents

Publication Publication Date Title
Gupta et al. Shining light on nanotechnology to help repair and regeneration
EP2754439A3 (en) Use of aminolevulinic acid derivatives
UY38263A (es) Compuestos de purinona y su uso en el tratamiento del cáncer
CL2019001079A1 (es) Métodos para usar indazol-3-carboxamidas y su uso como inhibidores de la vía de señalización de wnt/b-catenina.
AR078588A1 (es) Combinaciones de un inhibidor de pi3k y un inhibidor de mek
BRPI1002601E2 (pt) composição nanoestruturada de uso veterinário para administração de fármacos
EA201490647A1 (ru) Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции
WO2014141110A3 (en) Aminonitriles as kynurenine pathway inhibitors
CR20130377A (es) Métodos y productos de fármaco para tratar enfermedad de alzheimer
MX2020005738A (es) Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida.
JP2015516496A5 (enExample)
AR112284A1 (es) Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico
EA201591378A1 (ru) Композиции неорганических наночастиц в комбинации с ионизирующим излучением для лечения рака
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
JP2017503785A5 (enExample)
MX370361B (es) Preparación farmacéutica que contiene compuesto de ácido piridilaminoacético.
NZ629914A (en) New derivatives of 5-aminolevulinic acid and their use as photosensitizing agents
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
MX2017001855A (es) Compuestos biciclicos sustituidos.
ATE543492T1 (de) Behandlung von lungenkrebs
JP2015516419A5 (enExample)
JP2018537514A5 (enExample)
JP2019501161A5 (enExample)
JP2016538288A5 (enExample)
JP2014509637A5 (enExample)